Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension

Search results

• Finished

  INFLAMMASOMES AND INTERLEUKIN-18 SIGNALLING: NOVEL BIOMARKERS AND THERAPEUTIC TARGETS FOR KIDNEY DISEASE

  Drummond, G. (Primary Chief Investigator (PCI)), Hickey, M. (Chief Investigator (CI)), Mansell, A. (Chief Investigator (CI)), Sobey, C. G. (Chief Investigator (CI)) & Vinh, A. (Chief Investigator (CI))

  1/01/18 → 31/12/21

  Project: Research

• Targeting renal and vascular inflammation in hypertension

  Drummond, G., Latz, E., Mansell, A. & Sobey, C.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/14 → 31/12/16

  Project: Research

• NHMRC Research Fellowship

  Samuel, C. (Primary Chief Investigator (PCI))

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/13 → 31/12/18

  Project: Research

• Nox isoforms and chemokine receptors as therapeutic targets in vascular disease and stroke

  Drummond, G.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/11 → 31/12/16

  Project: Research